Literature DB >> 26398652

Erythropoietin resistance in end-stage renal disease patient with gastric antral vascular ectasia.

Desiree Ji Re Lee1, Juliana Fragata2, José Osmar Medina Pestana1, Sergio Draibe1, Maria Eugênia Canziani1, Miguel Cendoroglo1, Miguel Ângelo de Góes1.   

Abstract

We observed a case of recombinant human erythropoietin resistance caused by Gastric Antral Vascular Ectasia in a 40-year-old female with ESRD on hemodialysis. Some associated factors such as autoimmune disease, hemolysis, heart and liver disease were discarded on physical examination and complementary tests. The diagnosis is based on the clinical history and endoscopic appearance of watermelon stomach. The histologic findings are fibromuscular proliferation and capillary ectasia with microvascular thrombosis of the lamina propria. However, these histologic findings are not necessary to confirm the diagnosis. Gastric Antral Vascular Ectasia is a serious condition and should be considered in ESRD patients on hemodialysis with anemia and resistance to recombinant human erythropoietin because GAVE is potentially curable with specific endoscopic treatment method or through surgical procedure.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26398652     DOI: 10.5935/0101-2800.20150062

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  2 in total

1.  Gastric antral vascular ectasia should not be overlooked in erythropoietin resistance: a series of case reports.

Authors:  Laurynas Rimševičius; Domantas Galkauskas; Julius Lavinskas; Evelina Šestelinska; Ernesta Mačionienė; Agnė Laučytė-Cibulskienė; Skirmantė Rėkutė; Marius Miglinas
Journal:  Acta Med Litu       Date:  2018

2.  Clinical study of Shengxuening tablet combined with rHuEPO for the treatment of renal anemia of maintenance hemodialysis patients.

Authors:  Xin Cheng; Guojun Yu; Jiangping Hu; Xuefeng Xu; Fang Luo; Ping Shen; Guosheng Zhang; Ning Yang
Journal:  Exp Ther Med       Date:  2016-04-28       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.